MX2020009764A - Composicion topica. - Google Patents
Composicion topica.Info
- Publication number
- MX2020009764A MX2020009764A MX2020009764A MX2020009764A MX2020009764A MX 2020009764 A MX2020009764 A MX 2020009764A MX 2020009764 A MX2020009764 A MX 2020009764A MX 2020009764 A MX2020009764 A MX 2020009764A MX 2020009764 A MX2020009764 A MX 2020009764A
- Authority
- MX
- Mexico
- Prior art keywords
- polyaphron dispersion
- composition
- topical composition
- tocopherol
- alpha
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000000699 topical effect Effects 0.000 title abstract 2
- 239000006185 dispersion Substances 0.000 abstract 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 abstract 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 abstract 1
- 229940087168 alpha tocopherol Drugs 0.000 abstract 1
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 229960001102 betamethasone dipropionate Drugs 0.000 abstract 1
- CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 abstract 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 abstract 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 abstract 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 abstract 1
- LWQQLNNNIPYSNX-UROSTWAQSA-N calcipotriol Chemical compound C1([C@H](O)/C=C/[C@@H](C)[C@@H]2[C@]3(CCCC(/[C@@H]3CC2)=C\C=C\2C([C@@H](O)C[C@H](O)C/2)=C)C)CC1 LWQQLNNNIPYSNX-UROSTWAQSA-N 0.000 abstract 1
- 229960002882 calcipotriol Drugs 0.000 abstract 1
- 239000012071 phase Substances 0.000 abstract 1
- 229960000984 tocofersolan Drugs 0.000 abstract 1
- 239000002076 α-tocopherol Substances 0.000 abstract 1
- 235000004835 α-tocopherol Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a una composición para aplicación tópica que comprende una dispersión de poliafrón, comprendiendo la dispersión de poliafrón una fase acuosa continua y al menos una fase oleosa discontinua, en donde la dispersión de poliafrón comprende calcipotriol, dipropionato de betametasona, alfa-tocoferol e hidroxianisol butilado, y en donde la composición tiene un pH de 7.75 ± 0.5.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18162664.9A EP3542788A1 (en) | 2018-03-19 | 2018-03-19 | Topical composition comprising calcipotriol and betamethasone dipropionate |
PCT/EP2019/056735 WO2019179958A1 (en) | 2018-03-19 | 2019-03-18 | Topical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020009764A true MX2020009764A (es) | 2020-10-08 |
Family
ID=61691823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020009764A MX2020009764A (es) | 2018-03-19 | 2019-03-18 | Composicion topica. |
Country Status (23)
Country | Link |
---|---|
US (2) | US11696919B2 (es) |
EP (3) | EP3542788A1 (es) |
JP (2) | JP7506603B2 (es) |
KR (2) | KR102614025B1 (es) |
CN (2) | CN111867563A (es) |
AU (1) | AU2019239544B2 (es) |
BR (1) | BR112020019075A2 (es) |
CA (1) | CA3093999A1 (es) |
CY (1) | CY1124719T1 (es) |
DK (1) | DK3768241T3 (es) |
ES (1) | ES2896931T3 (es) |
HR (1) | HRP20211759T1 (es) |
HU (1) | HUE056223T2 (es) |
IL (1) | IL277213B1 (es) |
LT (1) | LT3768241T (es) |
MX (1) | MX2020009764A (es) |
PH (1) | PH12020551467A1 (es) |
PL (1) | PL3768241T3 (es) |
PT (1) | PT3768241T (es) |
RS (1) | RS62492B1 (es) |
SG (1) | SG11202008698QA (es) |
SI (1) | SI3768241T1 (es) |
WO (1) | WO2019179958A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201701583D0 (en) | 2017-01-31 | 2017-03-15 | Drug Delivery Solutions Ltd | Topical composition |
CN113092601B (zh) * | 2021-03-02 | 2022-12-20 | 苏州市药品检验检测研究中心 | 一种化妆品中倍他米松17-丙酸酯及倍他米松21-丙酸酯的检测方法 |
Family Cites Families (123)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4486333A (en) | 1981-04-10 | 1984-12-04 | Felix Sebba | Preparation of biliquid foam compositions |
JPS59222409A (ja) | 1983-06-01 | 1984-12-14 | Nippon Redarii Kk | 消炎鎮痛ゲル軟膏剤 |
CA1272953A (en) | 1984-10-08 | 1990-08-21 | Yuji Makino | Pharmaceutical composition for external use containing active-type vitamin d.sub.3 |
JPH07553B2 (ja) | 1985-12-09 | 1995-01-11 | 佐藤製薬株式会社 | フイルム状製剤 |
ZA888819B (en) | 1987-12-02 | 1990-07-25 | Ici Australia Operations | Process for preparing explosive |
US4900552A (en) | 1988-03-30 | 1990-02-13 | Watson Laboratories, Inc. | Mucoadhesive buccal dosage forms |
US4944938A (en) | 1988-12-16 | 1990-07-31 | Colgate-Palmolive Company | Antiperspirant and deodorant |
US4999198A (en) | 1989-03-23 | 1991-03-12 | The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Polyaphrons as a drug delivery system |
US5185150A (en) | 1990-08-24 | 1993-02-09 | Wisconsin Alumni Research Fdn. | Cosmetic compositions containing 19-nor-vitamin D compounds |
ATE150304T1 (de) | 1990-09-04 | 1997-04-15 | Fujisawa Pharmaceutical Co | Tricyclische verbindungen enthaltende salben |
ES2123505T3 (es) | 1990-09-07 | 1999-01-16 | Wisconsin Alumni Res Found | Nuevo uso de compuestos de 19-nor-vitamina d 1alfa-hidroxilada para tratar la psoriasis. |
US5840881A (en) | 1992-11-27 | 1998-11-24 | Takeda Chemical Industries, Ltd. | Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility |
USRE39706E1 (en) | 1993-01-15 | 2007-06-26 | Leo Pharma A/S | Crystalline form of a vitamin D analogue |
FR2710840B1 (fr) | 1993-10-04 | 1995-12-01 | Applic Transferts Technolo | Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique. |
US5549888A (en) | 1994-01-31 | 1996-08-27 | Procter & Gamble | Aqueous topical anti-acne compositions of low pH |
GB9405304D0 (en) | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
US6538039B2 (en) | 1994-04-29 | 2003-03-25 | Laboratoire L. Lafon | Pharmaceutical dosage form for transdermal administration |
FR2719220A1 (fr) | 1994-04-29 | 1995-11-03 | Lafon Labor | Nouvelle forme galénique pour l'administration transdermique. |
US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
IL110117A0 (en) | 1994-06-24 | 1994-10-07 | Univ Ben Gurion | Pharmaceutical compositions comprising vitamin-d analogs |
EP0786986B1 (en) | 1994-10-26 | 2002-03-20 | Novartis AG | Use of an unsaturated fatty alcohol |
KR0159145B1 (ko) | 1995-02-24 | 1998-12-01 | 강박광 | 피부 약물 전달 체계용 에멀젼 네트웍의 제조방법 |
US6238678B1 (en) | 1995-11-06 | 2001-05-29 | The Procter & Gamble Company | Methods of regulating skin appearance with vitamin B3 compound |
ES2177936T3 (es) | 1996-03-08 | 2002-12-16 | Disperse Ltd | Dispersion estable consistente en una espuma biliquida basada en aceite y un gel acuoso. |
US5660858A (en) | 1996-04-03 | 1997-08-26 | Research Triangle Pharmaceuticals | Cyclosporin emulsions |
KR100471341B1 (ko) | 1996-05-23 | 2005-07-21 | 제네시스 테크놀로지 가부시키가이샤 | 콘택트프로브및그것을구비한프로브장치 |
NL1003503C2 (nl) | 1996-07-04 | 1998-01-07 | Negma Steba International Dev | Farmaceutische samenstelling voor orale toediening. |
US5800832A (en) | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
US5955097A (en) | 1996-10-18 | 1999-09-21 | Virotex Corporation | Pharmaceutical preparation applicable to mucosal surfaces and body tissues |
JPH10139669A (ja) | 1996-11-05 | 1998-05-26 | Teijin Ltd | 脂漏性角化症治療剤 |
GB2326337A (en) | 1997-06-20 | 1998-12-23 | Phares Pharma Holland | Homogeneous lipid compositions for drug delivery |
JP4761093B2 (ja) | 1997-12-10 | 2011-08-31 | シクロスポリン セラポイティクス リミテッド | オメガ−3脂肪酸油を含む医薬組成物 |
US5990100A (en) | 1998-03-24 | 1999-11-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
EP1079813B1 (en) | 1998-04-29 | 2005-02-09 | Virotex Corporation | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
GB9814640D0 (en) | 1998-07-06 | 1998-09-02 | Fujisawa Pharmaceutical Co | New use |
US8263580B2 (en) | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
PT1178808E (pt) | 1999-04-23 | 2012-08-16 | Leo Pharma As | Composição farmacêutica não aquosa para utilização dérmica para o tratamento da psoríase compreendendo uma vitamina d, um corticosteróide e de um componente solvente |
US6200581B1 (en) | 1999-04-28 | 2001-03-13 | Dow Corning Corporation | Elastomeric silicone terpolymer |
DE19938668B4 (de) | 1999-08-14 | 2006-01-26 | Bausch & Lomb Inc. | Tränenersatzmittel |
US6562370B2 (en) | 1999-12-16 | 2003-05-13 | Dermatrends, Inc. | Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers |
ATE275378T1 (de) | 2000-02-22 | 2004-09-15 | Color Access Inc | Wässrige kosmetische gele |
AU7323001A (en) | 2000-07-07 | 2002-01-21 | Av Topchiev Inst Petrochemical | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
EP1331927B1 (en) | 2000-10-27 | 2007-12-12 | Leo Pharma A/S | Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
RU2276177C2 (ru) | 2001-05-01 | 2006-05-10 | Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук | Получение гидрофильных, чувствительных к давлению адгезивов с оптимизированными адгезионными свойствами |
WO2002096418A1 (en) | 2001-05-25 | 2002-12-05 | Valley Forge Pharmaceuticals | Pirenzepine ophthalmic gel |
US6585997B2 (en) | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
ATE397902T1 (de) | 2001-11-30 | 2008-07-15 | Koninkl Philips Electronics Nv | Bildverarbeitungsverfahren und system zum hervorheben von strukturen in verrauschten bildern |
GB0202312D0 (en) | 2002-01-31 | 2002-03-20 | Disperse Technologies Plc | Polyaphron fuel compositions |
GB0214793D0 (en) | 2002-06-26 | 2002-08-07 | Disperse Technologies Plc | Biliquid foam entrapment |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7053124B2 (en) | 2002-11-06 | 2006-05-30 | Disperse Limited | Aerosol delivery systems |
US20050026877A1 (en) | 2002-12-03 | 2005-02-03 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
GB0307866D0 (en) | 2003-04-04 | 2003-05-14 | Novartis Ag | Pharmaceutical composition |
US20050020546A1 (en) | 2003-06-11 | 2005-01-27 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
WO2005001643A2 (en) | 2003-06-21 | 2005-01-06 | J Maev Jack Ivan | Method and apparatus for encouraged visitation web advertising |
FR2856301B1 (fr) | 2003-06-23 | 2007-08-03 | Galderma Res & Dev | Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile |
ATE460206T1 (de) | 2003-07-01 | 2010-03-15 | Skinsure Internat Ltd | Barriereformulierung mit einer emulsion auf silikonbasis |
WO2005004989A2 (en) | 2003-07-01 | 2005-01-20 | Todd Maibach | Film comprising therapeutic agents |
GB0317869D0 (en) | 2003-07-30 | 2003-09-03 | Disperse Ltd | Improved drug delivery system |
GB0317868D0 (en) | 2003-07-30 | 2003-09-03 | Disperse Ltd | Biliquid foams with a high alcohol content and products formulated therefrom |
JP2007502823A (ja) | 2003-08-15 | 2007-02-15 | キューエルティー・ユーエスエイ・インコーポレーテッド | 接着性および生体侵食性の経粘膜薬物送達システム |
US20050059583A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
JP2005123083A (ja) | 2003-10-17 | 2005-05-12 | Dainippon Screen Mfg Co Ltd | 塗布組成物および有機el素子の製造方法 |
FR2862540B1 (fr) | 2003-11-21 | 2007-03-30 | Galderma Res & Dev | Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile |
JP2007511578A (ja) | 2003-11-21 | 2007-05-10 | ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ | ビタミンdの投与のためのスプレー可能な組成物 |
GB0401101D0 (en) | 2004-01-19 | 2004-02-18 | Disperse Ltd | Dispersions |
GB0404403D0 (en) | 2004-02-27 | 2004-03-31 | Disperse Ltd | Dispersions |
US20050249757A1 (en) | 2004-05-06 | 2005-11-10 | Glenmark Pharmaceuticals Limited | Pharmaceutical cream formulations |
FR2871697B1 (fr) | 2004-06-17 | 2007-06-29 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile |
FR2871699A1 (fr) | 2004-06-17 | 2005-12-23 | Galderma Sa | Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie |
FR2871695B1 (fr) | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises |
FR2871694B1 (fr) | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises |
FR2871696B1 (fr) | 2004-06-17 | 2006-11-10 | Galderma Sa | Composition topique pour le traitement du psoriasis |
FR2871700B1 (fr) | 2004-06-17 | 2006-11-17 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse |
FR2871693B1 (fr) | 2004-06-17 | 2006-08-25 | Galderma Sa | Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis |
FR2871698B1 (fr) | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse |
JP2008502647A (ja) | 2004-06-17 | 2008-01-31 | ガルデルマ・ソシエテ・アノニム | シリコーン剤、コルチコステロイドおよびビタミンdまたはその誘導体を含む乾癬治療用組成物 |
PL1771180T5 (pl) | 2004-06-17 | 2011-04-29 | Galderma Sa | Kompozycja w postaci sprayu zawierająca kombinację propionianu klobetazolu i kalcytriolu, fazę alkoholową i fazę olejową |
WO2005123090A1 (en) | 2004-06-17 | 2005-12-29 | Galderma S.A. | Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase |
IT1333365B1 (it) | 2004-09-09 | 2006-04-11 | Alberto Fiorenzi | Apparecchiatura e procedimento per realizzare una vela e relativa vela realizzata |
CA2578176C (en) | 2004-11-09 | 2013-09-24 | Novagali Pharma Sa | Ophthalmic emulsions containing an immunosuppressive agent |
KR100678829B1 (ko) | 2004-12-06 | 2007-02-05 | 한미약품 주식회사 | 타크로리무스의 경구용 마이크로에멀젼 조성물 |
ZA200706455B (en) * | 2005-01-05 | 2009-02-25 | Novacea Inc | Prevention of thrombotic disorders with active vitamin D compounds or mimics thereof |
EP1865896A1 (en) | 2005-03-14 | 2007-12-19 | MacroChem Corporation | Enhancement of macrolide penetration through human skin |
EP1874320A1 (en) | 2005-04-19 | 2008-01-09 | Galderma S.A. | Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology |
GB0508827D0 (en) | 2005-04-29 | 2005-06-08 | Novartis Ag | Cosmeceutical composition |
JP5612263B2 (ja) | 2005-06-01 | 2014-10-22 | スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド | ビタミン製剤 |
FR2889662B1 (fr) | 2005-08-11 | 2011-01-14 | Galderma Res & Dev | Emulsion de type huile-dans-eau pour application topique en dermatologie |
US20070048369A1 (en) | 2005-08-26 | 2007-03-01 | National Starch And Chemical Investment Holding Corporation | Mucosal delivery tablet |
KR100658436B1 (ko) | 2005-12-09 | 2006-12-27 | 한국화학연구원 | 아데노실코발라민 함유 피부질환 치료용 외용제 조성물 |
SI2719388T1 (sl) | 2006-02-16 | 2019-06-28 | Anacor Pharmaceuticals, Inc. | Majhne molekule, polnjene z borom, kot učinkovine proti vnetjem |
WO2007120910A1 (en) | 2006-04-14 | 2007-10-25 | Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The Univ. Of Nevada, Reno | Arsenic absorbing composition and methods of use |
EP2023918B1 (en) | 2006-05-19 | 2011-03-23 | Scynexis, Inc. | Cyclosporins for the treatment and prevention of ocular disorders |
US8303944B2 (en) | 2006-08-11 | 2012-11-06 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
BRPI0715636A2 (pt) * | 2006-08-29 | 2013-07-02 | Teva Pharma | composiÇÕes farmacologicamente ativas estÁveis incluindo compostos contendo vitamina d e corticosteràide com compatibilidade para ph baixo |
EP1970047A1 (en) | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Polyaphron topical composition with a corticosteroid |
US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
EP1970049A1 (en) | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Polyaphron topical composition with vitamin D and corticosteroid |
EP1970048A1 (en) | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Polyaphron topical composition with vitamin D |
GB0712389D0 (en) | 2007-06-26 | 2007-08-01 | Drug Delivery Solutions Ltd | A Pharmaceutical composition |
EP2008651A1 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A bioerodible patch |
CA2730221C (en) | 2007-07-09 | 2016-02-02 | Novagali Pharma Sa | Oil in water emulsion comprising nsaids and quaternary ammonium halides |
US8412809B2 (en) | 2007-10-24 | 2013-04-02 | International Business Machines Corporation | Method, apparatus and computer program product implementing multi-tenancy for network monitoring tools using virtualization technology |
EP2564853B1 (en) | 2007-12-04 | 2019-02-27 | Santen SAS | Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
EP3246034A1 (en) | 2008-03-06 | 2017-11-22 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-inflammatory agents |
PT2400951T (pt) | 2009-02-25 | 2018-11-26 | Mayne Pharma Llc | Composições de espuma tópica |
US20110009339A1 (en) | 2009-04-14 | 2011-01-13 | Allergan, Inc | Method of treating blurred vision and other conditions of the eye with cyclosporin compositions |
US20100272875A1 (en) | 2009-04-24 | 2010-10-28 | Monsanto Technology Llc | Omega-3 enriched cereal, granola, and snack bars |
WO2010127301A1 (en) | 2009-05-01 | 2010-11-04 | Allergan, Inc. | Method of treating allergic conjunctivitis with cyclosporin compositions |
US20100286101A1 (en) * | 2009-05-07 | 2010-11-11 | Jason Carbol | Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability |
US9480645B2 (en) | 2009-06-02 | 2016-11-01 | Abbott Medical Optics Inc. | Omega-3 oil containing ophthalmic emulsions |
JP5833007B2 (ja) | 2009-08-31 | 2015-12-16 | ドクター・レディーズ・ラボラトリーズ・リミテッド | ステロイドを含む局所製剤 |
EP2308468A1 (en) | 2009-10-08 | 2011-04-13 | Novaliq GmbH | Novel pharmaceutical composition comprising a macrolide immunosuppressant drug |
EA027869B1 (ru) | 2010-02-17 | 2017-09-29 | Велоксис Фармасьютикалз А/С | Стабилизированная композиция такролимуса |
US8784780B2 (en) * | 2010-06-11 | 2014-07-22 | Precision Dermatology, Inc. | High oil-content emollient aerosol foam compositions |
KR101619077B1 (ko) | 2010-06-11 | 2016-05-10 | 레오 파마 에이/에스 | 비타민 d 유사체 및 코르티코스테로이드를 포함하는 약제학적 분무 조성물 |
WO2012011192A1 (ja) | 2010-07-23 | 2012-01-26 | マルホ株式会社 | タクロリムスを含有する水中油型クリーム状組成物 |
HUE045467T2 (hu) | 2011-03-14 | 2020-01-28 | Drug Delivery Solutions Ltd | Szemészeti készítmény |
DK3383363T3 (da) | 2015-11-30 | 2021-01-18 | Anacor Pharmaceuticals Inc | Topiske farmaceutiske formuleringer til behandling af inflammatorisk-relaterede tilstande |
RU2741504C2 (ru) | 2016-04-04 | 2021-01-26 | Драг Деливери Солюшнз Лимитед | Композиция для местного применения, включающая такролимус |
RU2018141796A (ru) | 2016-05-25 | 2020-06-25 | Гленмарк Фармасьютикалс Лимитед | Стабильные композиции луликоназола для местного применения |
CN108815174A (zh) * | 2018-05-25 | 2018-11-16 | 昆山普瑞凯纳米技术有限公司 | 一种改良型脂溶性组合物及其制备方法 |
-
2018
- 2018-03-19 EP EP18162664.9A patent/EP3542788A1/en not_active Withdrawn
-
2019
- 2019-03-18 CN CN201980019695.9A patent/CN111867563A/zh active Pending
- 2019-03-18 SI SI201930129T patent/SI3768241T1/sl unknown
- 2019-03-18 AU AU2019239544A patent/AU2019239544B2/en active Active
- 2019-03-18 PL PL19709992T patent/PL3768241T3/pl unknown
- 2019-03-18 LT LTEPPCT/EP2019/056735T patent/LT3768241T/lt unknown
- 2019-03-18 KR KR1020207029400A patent/KR102614025B1/ko active IP Right Grant
- 2019-03-18 DK DK19709992.2T patent/DK3768241T3/da active
- 2019-03-18 MX MX2020009764A patent/MX2020009764A/es unknown
- 2019-03-18 SG SG11202008698QA patent/SG11202008698QA/en unknown
- 2019-03-18 HU HUE19709992A patent/HUE056223T2/hu unknown
- 2019-03-18 US US16/982,281 patent/US11696919B2/en active Active
- 2019-03-18 CN CN202110793951.9A patent/CN113499343B/zh active Active
- 2019-03-18 WO PCT/EP2019/056735 patent/WO2019179958A1/en unknown
- 2019-03-18 BR BR112020019075-6A patent/BR112020019075A2/pt unknown
- 2019-03-18 PT PT197099922T patent/PT3768241T/pt unknown
- 2019-03-18 EP EP21189853.1A patent/EP3925600A1/en active Pending
- 2019-03-18 EP EP19709992.2A patent/EP3768241B1/en active Active
- 2019-03-18 IL IL277213A patent/IL277213B1/en unknown
- 2019-03-18 RS RS20211318A patent/RS62492B1/sr unknown
- 2019-03-18 JP JP2020550768A patent/JP7506603B2/ja active Active
- 2019-03-18 KR KR1020237042837A patent/KR20230172042A/ko not_active Application Discontinuation
- 2019-03-18 ES ES19709992T patent/ES2896931T3/es active Active
- 2019-03-18 HR HRP20211759TT patent/HRP20211759T1/hr unknown
- 2019-03-18 CA CA3093999A patent/CA3093999A1/en active Pending
-
2020
- 2020-09-14 PH PH12020551467A patent/PH12020551467A1/en unknown
-
2021
- 2021-11-09 CY CY20211100971T patent/CY1124719T1/el unknown
-
2023
- 2023-03-20 US US18/123,828 patent/US20230226077A1/en active Pending
- 2023-06-07 JP JP2023093697A patent/JP2023126762A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018001381A2 (pt) | material lubrificante para auxiliar um processo de usinagem e método de usinagem | |
BR112015031099A2 (pt) | supressor de poeira | |
BR112018009775A2 (pt) | sistemas de fertilizantes compostos | |
BR112015024674A2 (pt) | método para aumentar a capacidade de sobrevivência de um ou mais microrganismos benéficos e para revestir uma semente, e, composição | |
BR112019024785A2 (pt) | composto de bifenila ou sal do mesmo, composição farmacêutica, agente antineoplásico e uso | |
MX2017011884A (es) | Composiciones cosmeticas topicas contra radicales libres. | |
PH12020551467A1 (en) | Topical composition | |
BR112018007949A2 (pt) | ferramenta de campo petrolífero, método e sistema para operações de campo petrolífero. | |
PH12020550474A1 (en) | Topical pharmaceutical composition of adapalene and minocycline | |
MX2022003166A (es) | Moduladores de il-17a y usos de los mismos. | |
SG11201809851WA (en) | Method and system for starting application | |
EP4327880A3 (en) | Solid state form of ribociclib succinate | |
WO2018093241A3 (ko) | 디메틸술폭시드를 포함하는 단일 페이스트형 수경성 근관 충전재를 위한 조성물 | |
MX2016016108A (es) | Material de envasado. | |
BR112017015696A2 (pt) | ?método para preparar uma folha de metal, folha de metal e uso de uma solução aquosa? | |
BR112016029494A2 (pt) | ?método e sistema para fornecer linhas de vinco, material e recipiente de acondicionamento, e, ferramenta de pressionamento de linha de vinco? | |
EP3943083A4 (en) | SMALL MOLECULE PD-1/PD-L1 INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF WITH PD-L1 ANTIBODY, AND USES THEREOF | |
SA517390552B1 (ar) | مركبات بلورية مثبط امتصاص ثلاثي غير متوازن | |
BR112018003267A2 (pt) | chapa de aço | |
MX2021001258A (es) | Composicion topica. | |
MX2016008451A (es) | Agente de recubrimiento para lamina de acero al silicio, metodo de fabricacion para el mismo y metodo de recubrimiento de lamina de acero al silicio que usa el mismo. | |
BR112018014884A2 (pt) | produto para lavagem de roupas e pastilha | |
PH12015501985A1 (en) | Composition comprising a multifunctional viscosity modifying agent | |
GB2547812A (en) | Proppant composition and method | |
EP4361241A3 (en) | Tomato ketchup with improved storage stability |